CL2010001442A1 - Procedimiento de preparacion de una n-piridil-etoxicarboniletil-amida de un acido benzimidazolico, como intermediarios en la sintesis de etexilato de dabiogatran. - Google Patents
Procedimiento de preparacion de una n-piridil-etoxicarboniletil-amida de un acido benzimidazolico, como intermediarios en la sintesis de etexilato de dabiogatran.Info
- Publication number
- CL2010001442A1 CL2010001442A1 CL2010001442A CL2010001442A CL2010001442A1 CL 2010001442 A1 CL2010001442 A1 CL 2010001442A1 CL 2010001442 A CL2010001442 A CL 2010001442A CL 2010001442 A CL2010001442 A CL 2010001442A CL 2010001442 A1 CL2010001442 A1 CL 2010001442A1
- Authority
- CL
- Chile
- Prior art keywords
- ethoxycarbonylethyl
- pyridyl
- amide
- synthesis
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Procedimiento para la preparación de n-(2-piridil)-n-(2-etoxicarboniletil)-amida-sal del ácido 1-metil-2-[n-[4-amidinofenil]-amino-metil]-bencimidazol-5-il-carboxílico, producto intermedio en la síntesis de etexilato de dabigatran.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08158364 | 2008-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2010001442A1 true CL2010001442A1 (es) | 2011-05-13 |
Family
ID=39863126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2010001442A CL2010001442A1 (es) | 2008-06-16 | 2010-12-15 | Procedimiento de preparacion de una n-piridil-etoxicarboniletil-amida de un acido benzimidazolico, como intermediarios en la sintesis de etexilato de dabiogatran. |
Country Status (20)
Country | Link |
---|---|
US (1) | US8471033B2 (es) |
EP (1) | EP2297132B1 (es) |
JP (1) | JP5265003B2 (es) |
KR (1) | KR101677915B1 (es) |
CN (1) | CN102066355B (es) |
AR (1) | AR072143A1 (es) |
AU (1) | AU2009259440B2 (es) |
BR (1) | BRPI0914788B1 (es) |
CA (1) | CA2728058C (es) |
CL (1) | CL2010001442A1 (es) |
DK (1) | DK2297132T3 (es) |
ES (1) | ES2536728T3 (es) |
HU (1) | HUE025533T2 (es) |
IL (1) | IL208371A (es) |
MX (1) | MX2010013258A (es) |
NZ (1) | NZ588488A (es) |
PL (1) | PL2297132T3 (es) |
RU (1) | RU2524212C2 (es) |
TW (1) | TWI440635B (es) |
WO (1) | WO2009153215A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005061623A1 (de) | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen |
NZ586868A (en) * | 2008-03-28 | 2012-02-24 | Boehringer Ingelheim Int | Process for preparing orally administered dabigatran formulations |
AU2009272796A1 (en) * | 2008-07-14 | 2010-01-21 | Boehringer Ingelheim International Gmbh | Method for manufacturing medicinal compounds containing dabigatran |
NZ592616A (en) | 2008-11-11 | 2013-04-26 | Boehringer Ingelheim Int | Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy |
US8399678B2 (en) | 2009-11-18 | 2013-03-19 | Boehringer Ingelheim International Gmbh | Process for the manufacture of dabigatran etexilate |
US9006448B2 (en) | 2010-12-06 | 2015-04-14 | Msn Laboratories Private Limited | Process for the preparation of benzimidazole derivatives and its salts |
HUP1100244A2 (hu) | 2011-05-11 | 2012-11-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Gyógyszeripari intermedierek és eljárás elõállításukra |
CN102633713B (zh) * | 2012-03-22 | 2013-12-11 | 南京工业大学 | 达比加群酯中间体及其制备方法、以及制备达比加群酯的方法 |
EP2834224B1 (en) | 2012-04-02 | 2018-06-06 | MSN Laboratories Limited | Process for the preparation of benzimidazole derivatives and salts thereof |
CN103420983B (zh) * | 2012-05-24 | 2015-07-08 | 天津药物研究院 | 达比加群酯衍生物及其制备方法和用途 |
CN102850326B (zh) * | 2012-06-19 | 2014-04-09 | 上海现代制药股份有限公司 | 一种达比加群酯中间体及其制备方法和应用 |
CN103772358A (zh) * | 2014-01-07 | 2014-05-07 | 万特制药(海南)有限公司 | 一种制备达比加群酯的合成方法 |
CN103992241B (zh) * | 2014-06-05 | 2016-08-24 | 雅本化学股份有限公司 | N-取代苯基甘氨酸的制备方法 |
CN104003977B (zh) * | 2014-06-05 | 2016-04-13 | 雅本化学股份有限公司 | N-(2-氯甲基-1-甲基-1h-苯并咪唑-5-酰基)-n-(吡啶-2-基) -3-氨基丙酸乙酯的制备方法 |
CN105348148B (zh) * | 2015-11-30 | 2017-12-26 | 山东新华制药股份有限公司 | 制备达比加群酯中间体缩合物的杂质的草酸盐的方法 |
CN109232535A (zh) * | 2018-09-25 | 2019-01-18 | 重庆奥舍生物化工有限公司 | 一种非肽类凝血酶抑制剂达比加群酯的制备方法 |
CN116354952A (zh) * | 2023-01-06 | 2023-06-30 | 宿迁盛基医药科技有限公司 | 一种达比加群酯关键中间体的合成工艺 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19924818A1 (de) * | 1999-05-29 | 2000-11-30 | Bayer Ag | Substituierte Phenylcyclohexancarbonsäureamide |
EP1609784A1 (de) * | 2004-06-25 | 2005-12-28 | Boehringer Ingelheim Pharma GmbH & Co.KG | Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen |
DE102005061624A1 (de) | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen |
DE102005061623A1 (de) * | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen |
EP1956018A1 (de) * | 2007-02-06 | 2008-08-13 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Herstellung eines Benzimidazolderivats |
EP2271317B1 (de) * | 2008-03-28 | 2017-04-19 | Boehringer Ingelheim International GmbH | Verfahren zur herstellung von säurepellets |
NZ586868A (en) | 2008-03-28 | 2012-02-24 | Boehringer Ingelheim Int | Process for preparing orally administered dabigatran formulations |
EP2300431B1 (en) | 2008-06-16 | 2016-01-06 | Boehringer Ingelheim International GmbH | Process for the manufacture of an intermediate in the synthesis of dabigatran |
AU2009272796A1 (en) | 2008-07-14 | 2010-01-21 | Boehringer Ingelheim International Gmbh | Method for manufacturing medicinal compounds containing dabigatran |
US8399678B2 (en) * | 2009-11-18 | 2013-03-19 | Boehringer Ingelheim International Gmbh | Process for the manufacture of dabigatran etexilate |
-
2009
- 2009-06-12 HU HUE09765795A patent/HUE025533T2/en unknown
- 2009-06-12 AR ARP090102161A patent/AR072143A1/es active IP Right Grant
- 2009-06-12 NZ NZ588488A patent/NZ588488A/xx unknown
- 2009-06-12 WO PCT/EP2009/057266 patent/WO2009153215A1/de active Application Filing
- 2009-06-12 MX MX2010013258A patent/MX2010013258A/es active IP Right Grant
- 2009-06-12 CA CA2728058A patent/CA2728058C/en active Active
- 2009-06-12 AU AU2009259440A patent/AU2009259440B2/en active Active
- 2009-06-12 US US12/997,101 patent/US8471033B2/en active Active
- 2009-06-12 PL PL09765795T patent/PL2297132T3/pl unknown
- 2009-06-12 CN CN200980122791.2A patent/CN102066355B/zh active Active
- 2009-06-12 BR BRPI0914788A patent/BRPI0914788B1/pt active IP Right Grant
- 2009-06-12 KR KR1020107025345A patent/KR101677915B1/ko active IP Right Grant
- 2009-06-12 EP EP09765795.1A patent/EP2297132B1/de active Active
- 2009-06-12 DK DK09765795.1T patent/DK2297132T3/da active
- 2009-06-12 ES ES09765795.1T patent/ES2536728T3/es active Active
- 2009-06-12 RU RU2011101500/04A patent/RU2524212C2/ru active
- 2009-06-12 JP JP2011514003A patent/JP5265003B2/ja active Active
- 2009-06-15 TW TW098119967A patent/TWI440635B/zh active
-
2010
- 2010-10-03 IL IL208371A patent/IL208371A/en active IP Right Grant
- 2010-12-15 CL CL2010001442A patent/CL2010001442A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
RU2011101500A (ru) | 2012-07-27 |
AU2009259440B2 (en) | 2014-05-29 |
US20110118471A1 (en) | 2011-05-19 |
KR20110026412A (ko) | 2011-03-15 |
PL2297132T3 (pl) | 2015-07-31 |
NZ588488A (en) | 2012-08-31 |
WO2009153215A1 (de) | 2009-12-23 |
US8471033B2 (en) | 2013-06-25 |
IL208371A (en) | 2014-11-30 |
MX2010013258A (es) | 2011-05-02 |
TW201008925A (en) | 2010-03-01 |
ES2536728T3 (es) | 2015-05-28 |
KR101677915B1 (ko) | 2016-11-21 |
EP2297132A1 (de) | 2011-03-23 |
TWI440635B (zh) | 2014-06-11 |
DK2297132T3 (da) | 2015-05-26 |
AU2009259440A1 (en) | 2009-12-23 |
RU2524212C2 (ru) | 2014-07-27 |
JP2011524403A (ja) | 2011-09-01 |
CN102066355B (zh) | 2015-07-01 |
CN102066355A (zh) | 2011-05-18 |
EP2297132B1 (de) | 2015-02-25 |
AR072143A1 (es) | 2010-08-11 |
BRPI0914788A2 (pt) | 2015-08-11 |
HUE025533T2 (en) | 2016-05-30 |
JP5265003B2 (ja) | 2013-08-14 |
CA2728058A1 (en) | 2009-12-23 |
IL208371A0 (en) | 2010-12-30 |
CA2728058C (en) | 2016-05-17 |
BRPI0914788B1 (pt) | 2020-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2010001442A1 (es) | Procedimiento de preparacion de una n-piridil-etoxicarboniletil-amida de un acido benzimidazolico, como intermediarios en la sintesis de etexilato de dabiogatran. | |
WO2013150545A3 (en) | Process for preparation of benzimidazole derivatives and salts thereof | |
HK1217487A1 (zh) | 用於治療成癮的作為乙醛脫氫酶- 抑制劑的 -氧基- -二氫-吡啶- -基 -芐基 -苯甲酰胺衍生物 | |
DOP2016000285A (es) | Procedimiento para la preparación de 4-{4-[({[4-cloro-3-(trifluorometil)fenil]amino}carbonil)amino]-3-fluorofenoxi}-n-metilpiridina-2-carboxamida, sus sales y su monohidrato | |
TW201129555A (en) | Process for the manufacture of dabigatrane etexilate | |
ECSP099509A (es) | Procedimiento para la preparación de un derivado de bencimidazol | |
MX350121B (es) | Derivados de n-(3-carbamoilfenil)-1h-pirazol-5-carboxamida y el uso de los mismos para el control de plagas de animales. | |
AP2013007233A0 (en) | l)-3-(trifluoromethyl phenylÜ benzamide solubilizeModified release of 4-methyl-3-[[4-(3-pyridinyl)-2- pyrimidinyl]amino]-N-5-(4-methyl-IH-imidazol-I-yd using organic acids | |
WO2012077136A3 (en) | Process for the preparation of benzimidazole derivatives and its salts | |
AR054278A1 (es) | Formas polimorficas del ester etilico del acido 3-((2-{ (4-(hexiloxicarbonilamino- imino-metil)- fenilamino)-metil} -1-metil-h-bencimidazol-5- carbonil) piridin-2-il-amino)-propionico | |
NO20081476L (no) | Substituerte benzimidazoler og fremgangsmater for fremstilling | |
EP3330254A3 (en) | Method and process for preparation and production of deuterated omega-diphenylurea | |
EP2751060A4 (en) | PROCESS FOR THE PRODUCTION OF BOTH SUCCINIC ACID AND BIOSOURCED 2,5-FURANDICARBOXYLIC ACID | |
CR20110554A (es) | Formulaciones líquidas de sales de 1-[2-(2,4-dimetilfenilsulfanil)-fenil-piperazina | |
WO2014020555A3 (en) | Improved process for preparing dabigatran etexilate mesylate | |
IL291738A (en) | Production method for 1-(4-(4-(4,3-dichloro-2-fluorophenylamino)-7-methoxyquinazoline-6-yloxy-piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used for this | |
EA201100517A1 (ru) | Способ получения дабигатрана и его промежуточные соединения | |
UA114601C2 (uk) | Спосіб одержання ривароксабану та проміжних сполук, які одержано в даному способі | |
DOP2011000064A (es) | Polimorfo b de la n-(2-aminofenil)-4-[n-(piridin-3-il)metoxicarbonilaminio-metil] benzamida (ms-275) | |
WO2013111163A3 (en) | Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof | |
BR112012020629A2 (pt) | forma cristalina, e, método para a terapia de um distúrbio | |
MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation | |
UY35108A (es) | Nuevo procedimiento de síntesis del (2e)-3-(3,4-dimetoxifenil) prop-2-enonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable | |
GEP20156350B (en) | New process for synthesis of ivabradine and their additional salts with pharmaceutically acceptable acid | |
EP2332932A4 (en) | NEW CRYSTALLINE FORMS OF 4- (2-AMINOPYRIDIN-4-YL) -3- (4-fluoro-PHENYL) -1- (1,4,5,6-TETRAHYDRO-6-OXOPYRIDAZIN-3-YL) -1H-PYRAZOLE -METHANESULPHONATE AND METHOD OF MANUFACTURING THEREOF |